InvestorsHub Logo
Followers 105
Posts 4897
Boards Moderated 0
Alias Born 10/06/2011

Re: Couch post# 180666

Tuesday, 01/26/2016 9:38:54 AM

Tuesday, January 26, 2016 9:38:54 AM

Post# of 404487
It does make me laugh to see that quote about Elite not having enough money to complete their P-3 trial. It is even more funny when you realize the FDA told them to keep the $2.3 Million NDA filing fee, so money does not seem a problem. In fact, given their current ratio (a financial ratio that shows their ability to meet their long and short term debt), investors should realize that Elite's current ratio is BETTER than Apple, AstraZeneca, Allergan, & Teva Pharma...FACT! And, here is a link to help with the math…

http://www.investopedia.com/terms/c/currentratio.asp
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News